Candidates / 4619

Nihon Tokushu Toryo Co., Ltd.4619・Chemicals

Activist stake: Murakami group (City Index Eleventh etc.). Of the listed companies with this trait in 2021–22, 1 in 5 was bought in the following four years or so — against 1 in 11 for all listed companies.

Taking every trait together, its score is 2.0x the average — #385 of 3,751. The closest type of deal is management buyout.

Score2.0xvs average; #385 of 3,751
Past, similar score1 in 5were bought (20%)
Closest typeMBO
Price-to-book0.96xmarket value ¥57.6bn

Why it looks like past targets

Score by type of buyer

Typevs average for the type
Buyout by the parent0.6x
Management buyout2.7x
Private equity4.0x
Strategic buyer1.5x

Ownership

Top 10 shareholders

HolderTypeStake
AUTONEUM HOLDING AGCompany14.4%
関西ペイント株式会社Company5.2%
株式会社三菱UFJ銀行Financial institution4.1%
明治安田生命保険相互会社Financial institution3.5%
株式会社中外Company3.4%
ニットク親和会Individual3.0%
株式会社ヒロタニCompany2.5%
株式会社三井住友銀行Financial institution1.8%
株式会社日本カストディ銀行(信託口)Custodian/nominee1.8%
交洋貿易株式会社Company1.7%

From the annual report for the year to 2026-03-31. Holder types are assigned by name and can be wrong (for example, a founder’s company can look like an operating company). Annual report (PDF, EDINET)

Key figures

Controlling shareholder (over 50%)
No
Largest corporate holder
14.4%
Founder family (individuals and their companies)
3.0%
Officers
0.7%
Net cash ÷ market value
51%
ROE
8.9%
Equity ratio
70%

Activist filings

Estimated cost = total acquisition funds ÷ shares held, from the latest report (or the previous one if the latest does not state the funds). Trades after the report's base date are not included. Stakes whose reports give no funding figure are left out. Share splits after the report are adjusted using the change in shares outstanding. Costs outside the stock's price range while held (0.8x the monthly low to 1.2x the high) are treated as reporting quirks (e.g. funds not updated after selling) and not shown. Stakes cut below 5% (mostly sold) are left out of the totals.

This site ranks listed companies by how closely their public filings (annual reports and large-shareholding reports) resemble past tender-offer and MBO targets. It is not a prediction that any company will be bought, is not based on any non-public information, and is not a recommendation to buy or sell. Not investment advice.

Updated 29 Sep 2026 00:48 JST